Product Information
ATORVASTATIN 40 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0370 per EA under NDC 16571013850. Its NADAC has been published 132 times since Feb 14, 2024.
FDA first approved this application on Jun 18, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571013850
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA209912FDA Approved
6/18/2018
TE Code
AB
On Market Since
10/20/2023
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 40 MG TABLET has been published 132 times since Feb 14, 2024, and over the history we have for it it has declined 46.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0370 per EA |
|---|---|
| All-time high | $0.0693 (Feb 14, 2024) |
| All-time low | $0.0370 (Aug 19, 2026) |
| 52-week high | $0.0449 |
| 52-week low | $0.0370 |
| Median price | $0.0458 |
| Average price | $0.0463 |
| Largest weekly change | +27.7% (Aug 21, 2024) |
| Weeks tracked | 132 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ATORVASTATIN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 40 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0370 per EA (NDC 16571013850), effective Aug 19, 2026.
How has the price of ATORVASTATIN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 40 MG TABLET has declined 46.6%. It has been tracked across 132 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 40 MG TABLET?
Since Feb 14, 2024, the NADAC for ATORVASTATIN 40 MG TABLET has ranged from a low of $0.0370 (Aug 19, 2026) to a high of $0.0693 (Feb 14, 2024), with a median of $0.0458 per EA.
Are there cheaper alternatives to ATORVASTATIN 40 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ATORVASTATIN 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ATORVASTATIN 40 MG TABLET?
ATORVASTATIN 40 MG TABLET (NDC 16571013850) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.